Skip to main content

Table 3 Detailed technical data and clinical outcomes of EUS-guided hepaticogastrostomy

From: Outcomes and limitations of endoscopic ultrasound-guided hepaticogastrostomy in malignant biliary obstruction

Factors

All (n = 53)

Procedure time, min, mean, (SD), [range]

31.2 (15.0) [11–84]

Diameter of the punctured intrahepatic duct, mm, mean, (SD), [range]

12.79 (4.8) [5,6,7,8,9,10,11,12,13,14,15,16,17,18,19,20,21]

Distance between the stomach and the punctured duct, mm, mean, (SD), [range]

22.74 (8.0) [10–33]

Side of puncture, n, (%)

 Liver segment II

7 (13.21%)

 Liver segment III

46 (86.79%)

Number of puncture, n, (%)

 1

32 (60.38%)

 2

13 (24.53%)

 3

3 (5.66%)

 4

5 (9.43%)

Technical success, n, (%)

52/53 (98.11%)

Complications of endoscopic treatment, n, (%)

10/53 (18.87%)

 Early complications

7 (13.21%)

 Late endoscopic treatment complications

3 (5.66%)

 The periprocedural mortality

4 (7.55%)

Clinical success of EUS-guided hepaticogastrostomy, n, (%)

46/53 (86.79%)